The purpose of the study is to compare the efficacy of levosimendan with that of dobutamine in patients with unstable hemodynamics (shock).
Official Title
Efficacy of Levosimendan in the Critically Ill Patients with Unstable Hemodynamics (the LICI study) – A Double Blind Randomized Pilot Study
Conditions
– Cardiogenic Shock- Septic Shock
Study Type
Interventional
Study Design
Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Further Details
Primary Outcomes: Resolution of shock stateSecondary Outcomes: Change in cardiac functions
Study Start
Study start: October 2004; Expected completion: June 2006
Eligibility & Criteria
Inclusion Criteria:- Reduced left ventricular systolic function – Hypotension – Anuria or oligouria Exclusion Criteria:- Less than 18 years old – Pregnant – Uncorrected valvular stenosis – Hypertrophic obstructive cardiomyopathy (HOCM) – Third degree AV block
Total Enrolment
40
Contact Details
Intensive Care Unit, Nepean Hospital, Penrith, New South Wales, 2750, Australia; Recruiting:- Anthony S McLean, MD +61-2-47342490 mcleana@wahs.nsw.gov.au – Stephen J Huang, PhD +61-247342320 huangs@wahs.nsw.gov.au
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
Related Articles
Need a health appointment?
Find and book a doctor, dentist, physio and more on Healthengine
Find a practitioner
